Semi-Parametric Prevalence Model Adjusts for Confounders in Tracking Cancer Drug Toxicities
A semi-parametric adaptation of the prevalence function accounts for patient confounding factors when evaluating the evolution of adverse events in ...
A semi-parametric adaptation of the prevalence function accounts for patient confounding factors when evaluating the evolution of adverse events in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.